Literature DB >> 11347765

Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications.

G Targher, L Zenari, L Bertolini, M Muggeo, G Zoppini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11347765     DOI： 10.2337/diacare.24.5.956

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot study.

Authors:  Sholeen T Nett; Janelle A Noble; Daniel L Levin; Natalie Z Cvijanovich; Monica S Vavilala; J Dean Jarvis; Heidi R Flori
Journal:  J Pediatr Intensive Care       Date:  2014

2.  Comparative insights into the regulation of inflammation: levels and predictors of interleukin 6 and interleukin 10 in young adults in the Philippines.

Authors:  Thomas W McDade; Paula S Tallman; Linda S Adair; Judith Borja; Christopher W Kuzawa
Journal:  Am J Phys Anthropol       Date:  2011-08-24       Impact factor: 2.868

3.  Altered kinetics of interleukin-6 and other inflammatory mediators during exercise in children with type 1 diabetes.

Authors:  Jaime S Rosa; Stacy R Oliver; Masato Mitsuhashi; Rebecca L Flores; Andria M Pontello; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Investig Med       Date:  2008-04       Impact factor: 2.895

4.  Redox status and immune function in type I diabetes families.

Authors:  E Matteucci; G Malvaldi; F Fagnani; I Evangelista; O Giampietro
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

5.  Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation.

Authors:  Krystallenia I Alexandraki; Christina Piperi; Panayiotis D Ziakas; Nikolaos V Apostolopoulos; Konstantinos Makrilakis; Vassiliki Syriou; Evanthia Diamanti-Kandarakis; Gregory Kaltsas; Anastasios Kalofoutis
Journal:  J Clin Immunol       Date:  2008-01-26       Impact factor: 8.317

6.  Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community.

Authors:  Margaret Dayhoff-Brannigan; Luigi Ferrucci; Kai Sun; Linda P Fried; Jeremy Walston; Ravi Varadhan; Jack M Guralnik; Richard D Semba
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-02       Impact factor: 6.053

7.  Factors Associated with Higher Pro-Inflammatory Tumor Necrosis Factor-α Levels in Young Women with Type 1 Diabetes.

Authors:  K K Danielson; R S Monson; T J LeCaire
Journal:  Exp Clin Endocrinol Diabetes       Date:  2016-03-23       Impact factor: 2.949

8.  Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model.

Authors:  S Hazra; Y P R Jarajapu; V Stepps; S Caballero; J S Thinschmidt; L Sautina; N Bengtsson; S Licalzi; J Dominguez; T S Kern; M S Segal; J D Ash; D R Saban; S H Bartelmez; M B Grant
Journal:  Diabetologia       Date:  2012-11-29       Impact factor: 10.122

Review 9.  COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Authors:  Cyril P Landstra; Eelco J P de Koning
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

10.  Association between IL-6 concentration and diabetes-related variables in DM1 patients with and without microvascular complications.

Authors:  Malgorzata Wegner; Aleksandra Araszkiewicz; Maria Piorunska-Stolzmann; Bogna Wierusz-Wysocka; Dorota Zozulinska-Ziolkiewicz
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.